Gemcitabine Production Cost Reports

The report provides a detailed analysis essential for establishing a Gemcitabine production plant. It encompasses all critical aspects necessary for Gemcitabine production, including the cost of Gemcitabine production, Gemcitabine plant cost, Gemcitabine production costs, and the overall Gemcitabine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Gemcitabine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Gemcitabine is an important chemotherapy medicine that is widely used in the treatment of several types of cancer. It is commonly prescribed for cancers such as non-small cell lung cancer, pancreatic cancer, breast cancer, bladder cancer, and ovarian cancer, where it helps slow the growth of harmful cells.

It works by interfering with the DNA replication process in cancer cells, slowing down or stopping their growth and division. It is often used alone or combined with other anticancer drugs to improve treatment results and support patients who need stronger therapy options. It is also used in ongoing medical research to develop improved cancer treatments and to study how tumour cells respond to different drug combinations.

The demand for Gemcitabine is mainly driven by its use as an intravenous injection in the treatment of various cancers, which significantly fuels its market growth. Its application as a chemotherapy agent in the treatment of various cancers, including pancreatic, non-small cell lung, breast, ovarian, and bladder cancers, also boosts its demand in the pharmaceutical industry. Its application as a drug in modern cancer treatment protocols in hospitals and oncology clinics to help slow the spread of harmful cells also fuels its demand in the medical sector. Its involvement as a reference compound for studying new therapies in cancer research and drug development also drives its market demand.

Moreover, technological improvements in synthesis, enhanced formulation methods, reliable supplier networks, and compliance with environmental and safety norms play a crucial role in directing procurement processes. Several factors, such as the cost and consistent availability of specialised raw materials, adherence to regulatory guidelines, and strict quality standards, also impact industrial Gemcitabine procurement.

Raw Material for Gemcitabine Production

According to the Gemcitabine production plant project report, the major raw materials for Gemcitabine production include Mannitol-derived 2,3-dihydroxypropanal (as acetonide) | Ethyl 2,2-dibromo-2-fluoroacetate | Methanesulfonyl Chloride | Cytosine | Trimethylsilyl Chloride.

Production Process of Gemcitabine

The extensive Gemcitabine production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of Gemcitabine begins with the acetonide derivative of 2,3-dihydroxypropanal, derived from mannitol, which undergoes a Reformatsky reaction with ethyl 2,2-dibromo-2-fluoroacetate to introduce the difluoromethyl group and form a protected alcohol. Then, the protected alcohol is benzylated to protect the hydroxyl group, followed by acid treatment, which removes the acetonide and leads to lactone formation through an intramolecular reaction of the free diol. The remaining hydroxyl group is also protected by benzylation, and the lactone is reduced to give a furanol intermediate, which is further activated by conversion into a mesylate. Then, this mesylated intermediate reacts with a silylated nucleobase, such as silylated cytosine (formed from Trimethylsilyl chloride), to form the nucleoside framework. Finally, deprotection of the benzyl groups with ammonia gives the active pharmaceutical ingredient, Gemcitabine.

Gemcitabine is a nucleoside analog used as an antineoplastic agent, which appears as an odourless white to off-white crystalline powder. The molecular formula of the compound is C9H11F2N3O4, and its molar mass is 263.20 g/mol. It is freely soluble in water and sparingly soluble in ethanol, while being insoluble in non-polar solvents. It has a solubility of 15.3 g/L in water, and its pKa value is 3.6. The compound has a melting point in the range of 173–175 degree Celsius and its boiling point is around 482.7 degree Celsius. It has a density of around 1.84 gm/cm3.

It should be stored in a tightly closed container away from moisture and light. It is a cytotoxic agent, and it can be harmful if inhaled, ingested, or absorbed through the skin. Therefore, it is recommended to use protective gloves, goggles, and clothing when handling the compound. Exposure to the substance may result in adverse effects such as myelosuppression, gastrointestinal disturbances, and liver enzyme abnormalities. It should only be handled in an appropriate laboratory or clinical environment.